Skip to content
  • Home
  • IOncology
  • Infectious Desease Frontier
  • IHepatology
  • Hematology Frontier
  • Conference topics
  • Experts Interviews
  • Informations
  • Live Broadcasting
  • Logout
MediaMedic

Connecting Medical Expertise through Media

  • Home
  • IOncology
  • Infectious Disease Frontier
  • International Hepatology
  • Hematology Frontier
  • Conference topics
  • Experts’ Interviews
  • Informations
  • Home
  • IOncology
  • Infectious Disease Frontier
  • International Hepatology
  • Hematology Frontier
  • Conference topics
  • Experts’ Interviews
  • Informations
Headlines
BOC Spotlight on Precision HER2 Therapy | Disitamab Vedotin Sets a New Benchmark for China’s Homegrown Innovation
2026.07.24
Pujiang Prostate Cancer Conference | Prof. Xiaojian Qin Discusses the Clinical Value and Surgical Experience of Primary Tumor Resection in Metastatic Prostate Cancer
2026.07.24
Pujiang Prostate Cancer Conference | Prof. Yong Yang: The Predictive Value of Deep PSA Response and Treatment Optimization in mHSPC
2026.07.24
ASCO China Voice | Professors Claudio Vernieri & Man Li: PALMARES-2 Highlights the Potential of CDK4/6 Inhibitor Beyond Progression and Combined Local Therapy
2026.07.24
Rethinking the Limits of Flexible Ureteroscopy — An Interview with Prof. John D. Denstedt
2026.07.24
Samsung Breast Cancer Forum | Wei Li: Building Patient-Centered Breast Centers Through Integrated Care
2026.07.20
Samsung Breast Cancer Forum | Benlong Yang: Building on Clinical Practice, Embracing Innovation, and Empowering the Next Generation of Breast Cancer Specialists
2026.07.20
23rd World Congress on Breast Healthcare | Xin Wang: Advancing Microsurgery to Improve the Quality of Breast Cancer Care
2026.07.20
23rd World Congress on Breast Healthcare | Xiaojing Guo: Digital Pathology and AI Are Advancing Precision Breast Cancer Care While China’s Experience Helps Shape Global Standards
2026.07.20
ASCO China Voice | Zhimin Shao, Zhonghua Wang, and Yin Liu: FUTURE2.0 Study Highlights Novel Combination Strategy for BLIS Triple-Negative Breast Cancer
2026.07.20
Posted inUroStream

BOC Spotlight on Precision HER2 Therapy | Disitamab Vedotin Sets a New Benchmark for China’s Homegrown Innovation

Posted by By Peter W. PENG 2026.07.24
Continue Reading
Posted inIOncology

Pujiang Prostate Cancer Conference | Prof. Xiaojian Qin Discusses the Clinical Value and Surgical Experience of Primary Tumor Resection in Metastatic Prostate Cancer

Posted by By Peng Longmei 2026.07.24
Continue Reading
EO2463 Peptide Immunotherapy Shows Promise in Follicular and Marginal Zone Lymphoma丨18-ICML

EO2463 Peptide Immunotherapy Shows Promise in Follicular and Marginal Zone Lymphoma丨18-ICML

Posted by By Peter W. PENG 2025.09.04
Editor's Note: At ICML conference, Professor Jose C. Villa Boas from Rochester, USA, was invited to present an oral report titled "EO2463 Peptide Immunotherapy in Combination with Lenalidomide and Rituximab…
Read More
New Era in Non-Hodgkin Lymphoma: Professor Franck Morschhauser on Breakthrough Phase I Results of a Novel BCL6 Degrader

New Era in Non-Hodgkin Lymphoma: Professor Franck Morschhauser on Breakthrough Phase I Results of a Novel BCL6 Degrader

Posted by By Mourabit Halima 2025.09.04
Editor's Note: The conference brought together top experts in lymphoma research from home and abroad, engaging in in-depth discussions on cutting-edge topics such as novel molecular targeted therapies and cell…
Read More
Extranodal Lymphoma Treatment Enters a New Era: IELSG’s 30-Year Journey of Academic Breakthroughs and Future Prospects丨Memorial Lecture

Extranodal Lymphoma Treatment Enters a New Era: IELSG’s 30-Year Journey of Academic Breakthroughs and Future Prospects丨Memorial Lecture

Posted by By Mourabit Halima 2025.09.03
Editor's Note: The 18th International Conference on Malignant Lymphoma (ICML) was held, gathering top experts in the lymphoma field in Lugano. At the prestigious John Ultmann Memorial Lecture, Professor Emanuele…
Read More
A New Era in Molecular Subtyping of Aggressive B-cell Lymphoma: Professor David W. Scott on Genomics-Guided Precision Therapy丨EHA 2025

A New Era in Molecular Subtyping of Aggressive B-cell Lymphoma: Professor David W. Scott on Genomics-Guided Precision Therapy丨EHA 2025

Posted by By Ren Jiamo 2025.09.03
Editor's Note: In 2025, the International Conference on Malignant Lymphoma (ICML) convened in Switzerland, bringing together the world's leading experts in the field of lymphoma. At the conference, Professor David…
Read More
The Journey of Disease Discovery: Professor Elaine Jaffe Reviews a Century of Lymphoma Diagnosis and Classification

The Journey of Disease Discovery: Professor Elaine Jaffe Reviews a Century of Lymphoma Diagnosis and Classification

Posted by By Peng Longmei 2025.09.03
Editor's Note: The International Hematologic Oncology Pathology Conference brought together top experts in hematopathology research from home and abroad for in-depth discussions on cutting-edge topics such as lymphoma diagnosis, classification…
Read More

Professor Bruce D. Cheson on Breakthroughs in Lymphoma Treatment: Innovation Pathways and Future Vision丨EHA 2025

Posted by By Mourabit Halima 2025.09.03
Editor's Note: The conference focused on the latest diagnostic and therapeutic advances in lymphoid system tumors, providing a cutting-edge academic exchange platform for the global oncology community. At this prestigious…
Read More
Professor Yuzhu Shi: The Comprehensive Value of Abdominal CT in Managing Post-Transplant Complications丨13th Lu Daopei Hematology Conference

Professor Yuzhu Shi: The Comprehensive Value of Abdominal CT in Managing Post-Transplant Complications丨13th Lu Daopei Hematology Conference

Posted by By Peter W. PENG 2025.09.03
On August 22–23, 2025, the 13th Lu Daopei Hematology Conference was held in Beijing, jointly organized by the Beijing Health Promotion Association and the Guangzhou Kapok Oncology and Rare Disease…
Read More
Professor Hui Wang: Advancing MRD Detection in AML—From Standardization and Automation Toward Personalized Treatment

Professor Hui Wang: Advancing MRD Detection in AML—From Standardization and Automation Toward Personalized Treatment

Posted by By Mourabit Halima 2025.09.03
On August 22–23, 2025, the 13th Lu Daopei Hematology Conference was held in Beijing, jointly organized by the Beijing Health Promotion Association and the Guangzhou Kapok Oncology and Rare Disease…
Read More
Professor Tong Wang Analyzes the Clinical Challenges of Multilineage Involvement in BCR::ABL1-Positive B-ALL丨13th Lu Daopei Hematology Conference

Professor Tong Wang Analyzes the Clinical Challenges of Multilineage Involvement in BCR::ABL1-Positive B-ALL丨13th Lu Daopei Hematology Conference

Posted by By Peter W. PENG 2025.09.02
On August 22–23, 2025, the 13th Lu Daopei Hematology Conference was held in Beijing, jointly organized by the Beijing Health Promotion Association and the Guangzhou Kapok Oncology and Rare Disease…
Read More
Professor Jianping Zhang: Optimizing Indication Selection, Timing, and Technical Innovations in Pediatric SAA Transplantation丨13th Lu Daopei Hematolog

Professor Jianping Zhang: Optimizing Indication Selection, Timing, and Technical Innovations in Pediatric SAA Transplantation丨13th Lu Daopei Hematolog

Posted by By Mourabit Halima 2025.09.02
On August 22–23, 2025, the 13th Lu Daopei Hematology Conference was held in Beijing, jointly organized by the Beijing Health Promotion Association and the Guangzhou Kapok Oncology and Rare Disease…
Read More

Posts pagination

Previous page 1 … 20
Recent Posts
  • BOC Spotlight on Precision HER2 Therapy | Disitamab Vedotin Sets a New Benchmark for China’s Homegrown Innovation
  • Pujiang Prostate Cancer Conference | Prof. Xiaojian Qin Discusses the Clinical Value and Surgical Experience of Primary Tumor Resection in Metastatic Prostate Cancer
  • Pujiang Prostate Cancer Conference | Prof. Yong Yang: The Predictive Value of Deep PSA Response and Treatment Optimization in mHSPC
  • ASCO China Voice | Professors Claudio Vernieri & Man Li: PALMARES-2 Highlights the Potential of CDK4/6 Inhibitor Beyond Progression and Combined Local Therapy
  • Rethinking the Limits of Flexible Ureteroscopy — An Interview with Prof. John D. Denstedt
Recent Comments
    Archives
    • July 2026
    • June 2026
    • May 2026
    • April 2026
    • March 2026
    • February 2026
    • January 2026
    • December 2025
    • November 2025
    • October 2025
    • September 2025
    • August 2025
    • July 2025
    • June 2025
    • May 2025
    • April 2025
    • March 2025
    • February 2025
    • January 2025
    • December 2024
    • November 2024
    • October 2024
    • September 2024
    • August 2024
    • July 2024
    • June 2024
    • May 2024
    • April 2024
    • March 2024
    • February 2024
    • January 2024
    • December 2023
    • November 2023
    • October 2023
    • August 2023
    Categories
    • Artificial intelligence
    • Hematology Frontier
    • Infectious Disease Frontier
    • International Hepatology
    • IOncology
    • Live broadcasting
    • Uncategorized
    • UroStream
    Post You Might Like
    Posted inUroStream
    BOC Spotlight on Precision HER2 Therapy | Disitamab Vedotin Sets a New Benchmark for China’s Homegrown Innovation
    Posted by By Peter W. PENG 2026.07.24
    Posted inIOncology
    Pujiang Prostate Cancer Conference | Prof. Xiaojian Qin Discusses the Clinical Value and Surgical Experience of Primary Tumor Resection in Metastatic Prostate Cancer
    Posted by By Peng Longmei 2026.07.24
    Posted inIOncology
    Pujiang Prostate Cancer Conference | Prof. Yong Yang: The Predictive Value of Deep PSA Response and Treatment Optimization in mHSPC
    Posted by By Mourabit Halima 2026.07.24
    Posted inIOncology
    ASCO China Voice | Professors Claudio Vernieri & Man Li: PALMARES-2 Highlights the Potential of CDK4/6 Inhibitor Beyond Progression and Combined Local Therapy
    Posted by By Mourabit Halima 2026.07.24
    • LinkedIn
    • Twitter
    • Mail
    Related Media:
    Copyright 2026 — MediaMedic. All rights reserved. Blogun WordPress Theme
    Paris, France
    Scroll to Top

    Welcome to Mediamedic 👋
    It’s nice to meet you.

    Dive into a world of trusted health insights. Subscribe for monthly updates straight to your inbox

    Privacy is part of our care. No spam, just wellness.

    🔒 Privacy policy

    Check your inbox or spam folder to confirm your subscription.

    • Facebook
    • X (Twitter)
    • LinkedIn
    • More Networks
    Share via
    Facebook
    X (Twitter)
    LinkedIn
    Mix
    Email
    Print
    Copy Link
    Copy link
    CopyCopied